Developing a Risk-scoring Model for Ankylosing Spondylitis Based on a Combination of HLA-B27, Single-nucleotide Polymorphism, and Copy Number Variant Markers.

CONCLUSION: Our AS-GRS could be used to identify individuals at high risk for AS before major symptoms appear, which may improve the prognosis for them through early treatment. PMID: 27909141 [PubMed - in process]
Source: J Rheumatol - Category: Rheumatology Authors: Tags: J Rheumatol Source Type: research